Using a mammary intraductal injection (MIND) model to mimic DCIS formation, Brummer et al. explored the role of CCR2 in minimally invasive SUM225 and highly invasive DCIS.com BC cells. Here, CCR2 is linked to ductal breast carcinoma in situ.